Clinical Trials Directory

Trials / Completed

CompletedNCT02734485

Deep TMS for the Treatment of Patients With Parkinson's Disease and Progressive Supranuclear Palsy

The Use of Deep TMS for the Treatment and Rehabilitation of Patients With Parkinson's Disease and Progressive Supranuclear Palsy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
IRCCS San Raffaele Roma · Academic / Other
Sex
All
Age
30 Years
Healthy volunteers
Not accepted

Summary

Background: Progressive supranuclear palsy (PSP) is a rare neuro-degenerative disease, counted among atypical parkinsonism (AP). Medical treatment and rehabilitation are extremely limited in AP, therefore it would be very useful to find new ways to improve motor and non motor symptoms in PSP. The Brainway Deep Transcranial magnetic stimulation (DTMS) is a new technology of TMS using a particular coil, i.e. H-coil, able to stimulate deeper regions of the brain. Only few studies in literature have evaluated the efficacy of DTMS in Parkinson's Disease and parkinsonism; in particular in PSP patients, a case report showed an improvement in language.

Detailed description

Materials and Methods: This study was a pilot, randomized, cross-over, double blind trial. It was designed to evaluate the efficacy of Deep TMS in terms of recovery of motor functions, freezing of gait, and cognitive decline in patients with PSP. Nineteen subject underwent 14 session of high frequency DTMS over a 4 weeks period. The target were the left Broca and dorsolateral prefrontal cortex.

Conditions

Interventions

TypeNameDescription
DEVICEactive Deep TMSThe Brainsway DTMS produces a time-varying magnetic field and, based on Faraday's Law, it can be assumed that a time-varying magnetic field generates an electrical current in a nearby conductive substance. The induced electric current in the cortex travels in an orthogonal path in the direction of the magnetic field with the maximum strength and current located beneath the coil in the helmet placed on the patient's head and transmits magnetic pulses to the patient's brain. The induced current is tangential to the scalp at the cortical surface, and decreases in magnitude with increasing depth. Patients underwent 12 sessions, 3 times a week, of repetitive DTMS using the novel H2-coil (Brainsway LDT).
DEVICEsham Deep TMSThe Sham DTMS consisted in the same protocol of active treatment with the same preparation of the subject and settings of the instrument but with an INACTIVE DTMS coil.

Timeline

Start date
2013-10-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2016-04-12
Last updated
2023-06-26

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02734485. Inclusion in this directory is not an endorsement.

Deep TMS for the Treatment of Patients With Parkinson's Disease and Progressive Supranuclear Palsy (NCT02734485) · Clinical Trials Directory